Enveric Biosciences Inc vs Global X Robo Global Robotics & Automation ETF — how do they compare? Enveric Biosciences Inc trades at $1.38 (market cap $5.32M), while Global X Robo Global Robotics & Automation ETF trades at $79.41. The key difference: Global X Robo Global Robotics & Automation ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | ROBO | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Sector/Thematic |
52-Week High | $17.40 | $90.34 |
52-Week Low | $1.28 | $60.72 |
Enterprise Value | $408.82K | — |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
ROBO Global Robotics and Automation Index ETF trades at $79.42, down 1.68% with bearish technical signals from moving averages. The ETF provides diversified exposure to robotics and AI infrastructure stocks across 79 holdings, with recent rebalancing emphasizing physical AI and automation themes. Current technical indicators show neutral oscillators but bearish momentum signals, with key support at $79 and resistance at $81-82 levels.
The ETF's outlook balances strong thematic growth potential in robotics and AI infrastructure against cyclical exposure and valuation concerns. Key opportunities include the shift toward physical AI and global reshoring trends, while risks involve sector concentration and market volatility. Analyst sentiment remains cautiously optimistic given the long-term automation growth story.
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →ROBO is a thematic ETF that tracks the global robotics and automation industry. It provides diversified exposure to companies leading in industrial robotics, 3D printing, and surgical systems, with holdings like Intuitive Surgical and Zebra Technologies.
Read more on ROBO →